Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Description Number 99.1 Press Release, dated May 22, 2026 ──────────────────────────────────────────────────────────────────────────────────────────── 104 Cover Page Interactive Data File (embedded within the inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NEUROONE MEDICAL TECHNOLOGIES CORPORATION Dated: May 22, 2026 By: /s/ David Rosa David Rosa Chief Executive Officer